Cantel Medical Corporation
(NYSE: CMD) announced today specific areas of focus and associated
actions to combat the COVID-19 virus. In these unprecedented times, the
company is concentrating on enhanced production, product innovation and
value-add COVID-19 education in support of first-responders and other
healthcare professionals.
“We are doing everything we can to contribute to the global effort focused on addressing the COVID-19 pandemic,” said George Fotiades,
President and Chief Executive Officer of Cantel. “Supporting those on
the front lines, in addition to our global employee base, is job one,
and we are working closely with distribution partners to ensure that our
masks, PPE and other infection prevention solutions are going to those
who are most in need. Infection prevention is the core of our company’s
mission, and we are doing everything possible to deliver key products
and services to serve and protect healthcare professionals.”
Cantel is working across divisions to bring critical products it
manufactures and sells to various end markets to best serve healthcare
providers on the front lines.
Cantel has focused on accelerating surgical earloop mask production
by its HuFriedyGroup dental division, increasing manufacturing to 24
hours a day, seven days a week at the organization’s two New York
manufacturing sites and expanding manufacturing lines to increase
production volume by over 50%. The enhanced hours and expanded
production capacity have enabled the production of over 4.4 million
masks per week to serve healthcare professionals. Recently, the
organization has increased its manufacturing output on protective face
shields by 50% and anticipates an increase of output by 100% in two
weeks. These products are being deployed to medical and dental
customers.
In addition to masks, HuFriedyGroup is focused on increasing sourcing
through sub-suppliers to increase product availability on key products
lines such as hand sanitizer, hand sanitizing wipes, protective eye wear, and surface disinfectants. These products span a variety of HuFriedyGroup brands including Crosstex, Hu-Friedy, and Palmero.
Cantel is also focused on innovating products that play a major role
on the front lines of combatting COVID-19. On the dental side, AdvantaClear™ surface
disinfectant is designed to clean and disinfect surfaces while
effectively killing a broad spectrum of disease-causing microorganisms
in one minute. Importantly, AdvantaClear surface disinfectant has been
added to the EPA List N: Disinfectants for Use Against SARS-CoV-2, and is classified as being effective against SARS-CoV-2, the cause of COVID-19.
Cantel’s ACTRIL™ Cold Sterilant surface
disinfectant, traditionally sold into the life sciences segment, is
another example of unique product innovation. ACTRIL Cold Sterilant is a
powerful disinfectant containing a proprietary mixture of 0.08%
peracetic acid and 1.0% hydrogen peroxide. It is effective against a
broad spectrum of organisms, including bacterial spores, fungal spores,
bacteria, mycobacteria, yeast, molds, and viruses. Cantel is actively
working with its medical division to offer this powerful disinfectant to
hospital customers to help in the fight against infections.
Cantel has made significant investments in the area of COVID-19 education. The COVID-19 Resource Center as well as a series of infection prevention webinars and podcasts, developed by the dental division, have been visited and attended by close to 20,000 people. The GreenLight Dental Compliance Center™,
a first-of-its-kind solution, provides a single, convenient online
portal that contains everything a dental practice needs to develop and
maintain a compliant infection prevention program. Cantel remains
focused on providing its customers a “Complete Circle of Protection”
that includes workflow management solutions, instrument reprocessing,
infection prevention, and compliance. The initial deployment of these
programs is to the dental community through the HuFriedyGroup business.
In the weeks and months ahead, Cantel will look to expand these key
educational resources to the Medivators business serving its medical
customers.
https://www.biospace.com/article/releases/cantel-announces-initiatives-to-help-fight-covid-19/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.